SCHEMBL7324060

SCHEMBL7324060

Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.52
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA12 O43570 1/20 0.47
MEN1 O00255 2/20 0.45
TSHR P16473 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 2/20 0.45
GFER P55789 1/20 0.45
KMT2A Q03164 1/20 0.45
EPHX2 P34913 8/20 0.44
PTGS2 P35354 2/20 0.41
MAPK14 Q16539 2/20 0.41
MAPT P10636 2/20 0.40
PSIP1 O75475 1/20 0.40
AXL P30530 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314318 0.83 USP8 (0.48) USP8CA1CA2CA9CA12
SCHEMBL14409476 0.80 EPHX2 (0.64) USP8CA1CA2CA9CA12
SCHEMBL7234775 0.77 EPHX2 (0.64) USP8CA1CA2CA9CA12
SCHEMBL7234160 0.77 KDM4E (0.58) USP8CA1CA2CA9CA12
SCHEMBL7324026 0.76 EPHX2 (0.55) EPHX2MAPT
SCHEMBL2730578 0.75 RAB9A (0.63) USP8CA1CA2CA9CA12
SCHEMBL7685096 0.72 USP8 (0.70) USP8CA1CA2CA9CA12
SCHEMBL12615169 0.72 RAB9A (0.68) USP8CA1CA2CA9CA12
SCHEMBL15070241 0.71 USP8 (0.77) USP8CA1CA2CA9CA12
SCHEMBL1924362 0.70 TP53 (0.50) MEN1TSHRRAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 USP8 4088/4885CA1 935/4885CA2 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.